The global medical aesthetics market is projected to reach USD 23.4 billion by 2027 from USD 13.9 billion in 2022, at a CAGR of 11.0% from 2022 to 2027. The market is expanding as a result of factors like the rising popularity of minimally invasive and noninvasive aesthetic procedures, the rising popularity of aesthetic procedures among geriatric patients, the accessibility of technologically advanced and user-friendly products, and the rising demand for aesthetic treatments among men. The availability and acceptance of alternative beauty and cosmetic goods, which are becoming more widely available, are, however, limiting the expansion of this market, as are the clinical risks and consequences connected with medical aesthetic operations.
The medical aesthetics business is very competitive, with both established companies and newcomers competing for the same market share. As of 2021, the key players operating in the global medical aesthetics market are Advanced Energy Industries, Alma Lasers (Isreal), ANIKA THERAPEUTICS, INC. (US), AbbVie Inc. (Ireland), Cynosure (US), Cutera (California), and El.En. S.p.A.(Italy), Inmode Ltd.(Israel), Lumenis Be Ltd. (Israel), Fotona (US), Galderma (Switzerland), Johnson & Johnson Services, Inc(US), Merz Pharma (US), Medytox. (South Korea), Sientra, Inc.(US), Huadong Medicine Co., Ltd (China), Bausch Health Companies Inc.(Canada), Candela Corporation. (US), Venus Concept(Canada), aeroloase(US), Sciton.(US), and Bohus BioTech AB(US) among others.
To know about the assumptions considered for the study download the pdf brochure
To further increase their market share in the global medical aesthetics market, these competitors have utilised a variety of strategies, including acquisitions, collaborations, and product releases. In 2021, a higher share of the global medical aesthetic was held by Alma Lasers (Israel), Cynosure (US), Galderma (Switzerland), AbbVie (Ireland), and Merz Pharma (US).
Alma Lasers :
Alma Lasers provides laser, radiofrequency, light-based, ultrasound, and plasma solutions for the aesthetic and surgical markets. It also provides safe and effective treatments and products for aesthetic and surgical procedures. The company operates through four business segments: Personal Care, Medical Aesthetics, Dental, and Injectables. The personal care business line offers at-home use products; the Medical Aesthetic business line offers products like Alma Duo and Alma PrimeX; the Dental line offers digital platforms and workflows for dentistry professionals and practitioners. The Injectable business line offers products such as neuromodulator toxin injectables and fat tissue transformation injectables.
Allergan plc, acquired by AbbVie Inc., develops, manufactures, and markets branded pharmaceuticals, devices, biologics, surgical, and regenerative medicine products. Allergan includes a wide range of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics & dermatology, gastroenterology, women’s health, urology, and anti-infective therapeutic categories. The company has a global presence with manufacturing sites in almost ten countries and operations in more than 100 countries. Allergan plc’s principal executive offices and administrative headquarters are in Dublin, Ireland.
Medical Aesthetics Market by Product (Botox, Dermal Filler, Chemical Peel, Liposuction, Fat Reduction, Skin Tightening, Breast Implant, Hair/Tattoo Removal, Thread Lift, Nail Treatment), End User (Medical Spa, Beauty Center) - Global Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE